Related Experiment Video

Updated: Jul 9, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Comparison of peripheral blood and bone marrow samples for detection of post transplant mixed chimerism

J Stumph, C L Vnencak-Jones, T Koyama

    Bone Marrow Transplantation
    |November 27, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
    08:53

    Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

    Published on: August 31, 2016

    Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
    10:11

    Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

    Published on: March 7, 2013

    Related Experiment Videos

    Last Updated: Jul 9, 2026

    Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
    11:59

    Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

    Published on: September 6, 2017

    Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
    08:53

    Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

    Published on: August 31, 2016

    Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
    10:11

    Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

    Published on: March 7, 2013

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Bone marrow failure and extramedullary hematopoiesis in McCune-Albright syndrome.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017

    GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.

    Bone marrow transplantation·2016

    Analysis of factor VIII gene inversion mutations in 166 unrelated haemophilia A families: frequency and utility in genetic counselling.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016

    Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant.

    Bone marrow transplantation·2013

    Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT.

    Bone marrow transplantation·2013

    Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies.

    Bone marrow transplantation·2012

    GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

    Bone marrow transplantation·2026

    Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

    Bone marrow transplantation·2026

    Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

    Bone marrow transplantation·2026

    Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT.

    Bone marrow transplantation·2026

    Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia.

    Bone marrow transplantation·2026

    Incidence and risk factors of Epstein-Barr virus infection and post-transplant lymphoproliferative disorder in paediatric haploidentical allogeneic hematopoietic stem cell transplantation.

    Bone marrow transplantation·2026

    Integrated Multi-Tissue Omics Identifies Acylcarnitine Accumulation as Shared Metabolic Marker of Diabetic Microangiopathy With Cross-Organ Validation.

    Investigative ophthalmology & visual science·2026

    Gut microbiota-derived metabolites and host interactions in fibrotic diseases: mechanisms, cross-organ signatures, and therapeutic opportunities.

    Frontiers in microbiology·2026

    Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific.

    Frontiers in oncology·2026

    Mitophagy as an active regulator of cardiac metabolic reprogramming.

    Frontiers in cardiovascular medicine·2026

    Regulatory mechanisms and interactions of mitophagy and ketone body metabolism in cardiac metabolism.

    Frontiers in cardiovascular medicine·2026

    The Methionine-Mitochondria Axis in Cancer: Metabolic Cross-Talk and Therapeutic Vulnerabilities.

    Current pharmacology reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us